New schizophrenia drug tested for safety and effectiveness
NCT ID NCT01626859
Summary
This study tested a new medication called MP-214 for people with schizophrenia. It involved 38 participants and lasted 12 weeks. The main goals were to see how the drug moves through the body, check its safety, and measure if it helps control symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Sakai, Osaka, Japan
Conditions
Explore the condition pages connected to this study.